Bade, Katarina J.
Mueller, Kevin T.
Sparks, Jeffrey A.
Article History
Accepted: 17 July 2024
First Online: 2 August 2024
Declarations
:
: Dr. Sparks has received research support from Boehringer Ingelheim, Bristol Myers Squibb, Janssen, and Sonoma Biotherapeutics unrelated to this work. He has performed consultancy for AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Inova Diagnostics, Janssen, Merck, Mustang, Optum, Pfizer, ReCor, Sana, Sobi, and UCB unrelated to this work. The funders had no role in the decision to publish or preparation of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard University, its affiliated academic health care centers, or the National Institutes of Health. The other authors report no conflicts of interest.
: Not applicable.